Aquatic Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,511
| Closed | -$353K | – | 1595 |
|
|
2025
Q1 | $353K | Buy |
10,511
+2,251
| +27% | +$75.5K | 0.01% | 824 |
|
|
2024
Q4 | $324K | Buy |
+8,260
| New | +$324K | 0.01% | 828 |
|
|
2024
Q3 | – | Sell |
-4,200
| Closed | -$164K | – | 1594 |
|
|
2024
Q2 | $164K | Sell |
4,200
-20,500
| -83% | -$799K | 0.01% | 801 |
|
|
2024
Q1 | $1.06M | Buy |
24,700
+5,200
| +27% | +$224K | 0.03% | 376 |
|
|
2023
Q4 | $898K | Buy |
19,500
+4,200
| +27% | +$193K | 0.02% | 499 |
|
|
2023
Q3 | $523K | Buy |
+15,300
| New | +$523K | 0.02% | 472 |
|
|
2023
Q2 | – | Sell |
-2,000
| Closed | -$72K | – | 1792 |
|
|
2023
Q1 | $72K | Buy |
+2,000
| New | +$72K | ﹤0.01% | 817 |
|
|
2022
Q2 | – | Sell |
-400
| Closed | -$12K | – | 1614 |
|
|
2022
Q1 | $12K | Sell |
400
-5,000
| -93% | -$150K | 0.02% | 627 |
|
|
2021
Q4 | $169K | Buy |
+5,400
| New | +$169K | 0.33% | 52 |
|